February 2024 – Page 14 – Get News Story

The Ventilators Market to Reach $2.56 Billion by 2029 – Exclusive Focus Insight Report by Arizton

“Global Ventilators Market Focus Insight Report by Arizton”

Get this Report for Lesser with Our Subscription Services

According to Arizton’s latest research report, the global ventilators market is growing at a CAGR of 6.50% from 2023 to 2029.

To Know More, Download the Free Sample Report: https://www.focusreports.store/request-sample/ventilators-market-focused-insights

Ventilators are vital to healthcare services, from hospitals to ambulatory healthcare services and homecare settings. The changing healthcare services in emerging markets and significant achieved development with developed countries consistently drive the ventilator market growth.

There are some other conditions, such as acute respiratory distress syndrome, asthma, cardiac arrest, pneumonia, collapsed lung, stroke, coma, drug overdose, hypercapnic respiratory failure, lung infection, myasthenia gravis, sepsis, an infection in the blood, upper spinal cord injuries, premature lung development (in babies) that will drive the market consistently in the upcoming period.

In 2023, North America emerged as the dominant player in the global ventilators market. Within North America, the United States stands out with the highest per capita healthcare expenditure, which has fueled the adoption of ventilators in homecare settings and driven significant demand. However, this high healthcare expenditure has also contributed to the complexity of the healthcare system in the US.

The market’s growth in North America is further propelled by technological advancements in ventilators, leading to the continuous introduction of new products. Additionally, factors such as the increasing geriatric population, prevalence of chronic diseases like cardiovascular diseases and diabetes, rising surgical procedures, and demand for emergency healthcare services have all contributed to the growing application of ventilators in the region.

North America’s ventilators market is highly competitive, with several prominent players striving to maintain their foothold by introducing new products to meet the rising demand. Key vendors in this market include Hamilton Medical, Koninklijke Philips, GE Healthcare, Medtronic, and Resmed. These companies are implementing various strategies such as mergers, acquisitions, partnerships, and collaborations with key vendors to expand their distribution networks. This is anticipated to drive market growth further during the forecast period.

For example, in 2022, ICU Medical’s acquisition of Smith plc aimed to bolster ICU Medical’s product line, including infusion therapy and ventilators, reflecting a strategic move to support market expansion and meet growing demand.

Competitive Overview

Many emerging med-tech companies pose a considerable threat to global players due to their innovative products and technologies. The market offers tremendous growth opportunities for both existing players and new entrants, which is attributable to a considerably large target patient population with COPD conditions.
Most prominent players in the market focus on implementing various strategies, such as new product launches and approvals, marketing and promotional activities, acquisitions, R&D initiatives, and strengthened distribution networks to enhance their revenue share and presence in the market.
Further, there has been an unprecedented surge in demand for ventilators since the COVID-19 outbreak. With the sudden surge in demand for ventilators, both global and domestic vendors are ramping up their production capabilities to meet the rising demand. Many vendors worldwide have increased their production capacities for ventilators by 50% to 200%.

Buy this Research @ https://www.focusreports.store/report/ventilators-market-focused-insights

Product Segmentation & Forecast

Interface
Invasive
Non-Invasive
Mobility
Standalone/Standard Ventilators

Portable Ventilators
Patient Group
Adults
Pediatrics/Neonates
Application
Critical Care
Emergency Care
Homecare
Neonatal Care
End-users
Hospitals
Homecare Settings
Emergency Care Providers
Others

Vendors List

KoninKlijke Philips
Hamilton Medical
Resmed
Medtronic plc
Vyaire Medicals

GE Healthcare
Schiller
Dragerwerk
ICU Medicals
Abronn FZE
A.B. Industries
Airon
Acutronic Medical Systems
Aeonmed
AgVa Healthcare
Air Liquide
Axcent Medical
Avasarala Technologies
Bio-Med Devices
Bunnel
Cardinal Health
Delux Scientific Surgo
Dima Italia
Fritz Stephan
Getinge

Hartwell Medical
HEYER Medical
Hill-rom Services
Lowenstein Medical Innovation
MEKICS
Narang Medical
Oceanic Medical Products
Mindray Bio-Medical Electronics
Saire Engineering International Group
S.I.E.M
SI Surgical
Skanray Technologies
Tecme
Triton Electronic Systems
Ventec Life Systems

Key Questions Answered in the Report:

What is the projected value of the global ventilators market by 2029?

What factors are driving the growth of the global ventilators market?

What segment holds the largest share in the ventilators market?

Table of Contents

CHAPTER – 1: Ventilators Market Overview

Executive Summary
Key Findings

CHAPTER – 2: Ventilators Market

GLOBAL: Projected Revenue of Ventilators Market (2023-2029; $Millions)

CHAPTER – 3: Ventilators Market Segmentation Data

GLOBAL: Projected Revenue by Interface (2023-2029; $Millions)
Invasive
Non-invasive
GLOBAL: Projected Revenue by Mobility (2023-2029; $Millions)
Standalone/Standard Ventilators
Portable Ventilators
GLOBAL: Projected Revenue by Patient Group (2023-2029; $Millions)
Adults
Pediatrics/Neonates
GLOBAL: Projected Revenue by Application (2023-2029; $Millions)
Critical Care
Emergency Care
Homecare
Neonatal Care

GLOBAL: Projected Revenue by End-user (2023-2029; $Millions)
Hospitals
Homecare Settings
Emergency Care Providers
Others

CHAPTER – 4: Key Regions Overview

North America: Projected Revenue of Ventilators Market (2023-2029; $Millions)
Projected Revenue of Ventilators Market in US
Projected Revenue of Ventilators Market in Canada
Europe: Projected Revenue of Ventilators Market (2023-2029; $Millions)
Projected Revenue of Ventilators Market in Germany
Projected Revenue of Ventilators Market in UK
Projected Revenue of Ventilators Market in France
Projected Revenue of Ventilators Market in Italy
Projected Revenue of Ventilators Market in Spain
APAC: Projected Revenue of Ventilators Market (2023-2029; $Millions)
Projected Revenue of Ventilators Market in China
Projected Revenue of Ventilators Market in Japan
Projected Revenue of Ventilators Market in India
Latin America: Projected Revenue of Ventilators Market (2023-2029; $Millions)

Projected Revenue of Ventilators Market in Brazil
Projected Revenue of Ventilators Market in Mexico
Projected Revenue of Ventilators Market in Argentina
Middle East & Africa: Projected Revenue of Ventilators Market (2023-2029; $Millions)
Projected Revenue of Ventilators Market in Turkey
Projected Revenue of Ventilators Market in Saudi Arabia
Projected Revenue of Ventilators Market in South Africa

CHAPTER – 5: Ventilators Market Prospects & Opportunities

Ventilators Market Opportunities & Trends
Ventilators Market Drivers
Ventilators Market Constraints

CHAPTER – 6: Ventilators Industry Overview

Ventilators Market – Competitive Landscape
Ventilators Market – Key Vendor Profiles
Ventilators Market – Other Prominent Vendors
Ventilators Market – Key Strategic Recommendations

CHAPTER – 7: Appendix

Research Methodology
Abbreviations
About Arizton

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.focusreports.store/report/ventilators-market-focused-insights

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Ventilators Market to Reach $2.56 Billion by 2029 – Exclusive Focus Insight Report by Arizton

Haledco.com – Shining a Light on the Future – Unveils Cutting-Edge LED Street Lighting Technology

Ho Chi Minh City, Vietnam – February 28, 2024 – LED street lights (den duong LED) are light products manufactured by HALEDCO – Vietnam’s leading intelligent lighting system supplier.

Dissimilar to standard high-intensity sodium or metal halide luminaires, LED road lights utilize the capabilities of Light-Emitting Diodes (LEDs) to provide unmatched efficiency, vitality savings, and sturdiness. These contemporary illuminations work as effective substitutions for conventional street lighting (den duong) frameworks, furnishing supreme lighting for streets, interstates, and metropolitan scenes. Hence, LED street lights bring revolutionary advancement, enabling reliable outdoor illumination while decreasing costs and environmental impact.

LED streetlights are of great help in city landscapes

By engineering LED luminaires to uncompromising durability standards, cyber-resilience, and future-proof compatibility, haledco.com empowers cities to progress ambitious LED conversion and innovative city initiatives with confidence.

Haledco.com: Pioneering LED Solutions

HALEDCO propels ingenuity and eco-consciousness throughout the metropolitan lighting industry. Boasting a multifaceted selection of LED street (den LED duong) lamps, Haledco accommodates the developing prerequisites of municipalities, infrastructure builders, and urban designers globally. In addition, it provides dependable, economically viable lighting resolutions that amplify visibility, security, and aesthetics within urban locales.

By consistently expanding research and incorporating creative developments, Haledco remains at the forefront of crafting high-caliber yet affordable LED solutions.

LED street lights at Haledco

Traditional high-pressure streetlights
LED street lights
Solar street lights
LED headlights

Solar lights help save energy.

In general, LED street lights (bong dien duong) are the most optimal choice, with many outstanding advantages compared to other types of lights.

HALEDCO ‘s LED street light portfolio provides the following unique benefits:

Ultra-Efficient Optical Design for Precise Light Control

To allow highly accurate photometry and light distribution on roads, paths, and public spaces, reducing spill light and further energy savings.

ThermiX® Cooling System for Reliable High-Power Operation

Haledco.com’s patented ThermiX® thermal management system utilizes advanced heat pipe and alloy heat sink technologies to ensure the reliable operation of the high-power LEDs at optimal efficiency levels.

Long Life >50,000 Hours for Low Maintenance

With an expected lifespan of 50,000 – 65,000 hours of continuous use, HALEDCO’s LED street lights (bong den duong) eliminate lamp replacement costs and disruptive maintenance processes for road lighting infrastructure for the foreseeable future.

Surge Protection and Waterproofing for Robust Reliability

Incorporating the latest advances in surge protection, electrical safety, and waterproof design, LED street lamps deliver extreme reliability and resilience, ensuring lighting continuity in all weather conditions.

Innovative Lighting Capability for Advanced Control

The LED streetlights are ready for intelligent lighting networks, enabling remote monitoring, dynamic dimming profiles, adaptive lighting levels, and data-driven maintenance planning to enhance energy efficiency and functionality.

LED streetlight products are used in road traffic

Class I Surge Protection Rating for Enhanced Durability

With a Class I rating, HALEDCO’s LED streetlights provide superior protection against electrical voltage fluctuations that impact performance.

IP66 Rating for Water & Dust Resistance

An IP66 rating ensures LED street lamps (den LED duong pho) withstand high-pressure water jets from any direction and prevent dust accumulation. This enables reliable operation in all weather conditions over years of use.

About Haledco

HALEDCO is a premier manufacturer and supplier of LED lighting (den LED chieu sang duong) solutions, specializing in LED street lights, floodlights, and lights. With a dedication to quality, performance, and customer satisfaction, HALEDCO empowers cities worldwide to sustainably enhance efficiency and cut public lighting costs for the next generation.

For inquiries, please visit: https://haledco.com/den-led/den-duong-led

Media Contact
Company Name: HALEDCO – LED Street Lights
Contact Person: Media Relations
Email: Send Email
Phone: 02437 918 122
Address:3D2 KDT, Cau Dien Bac Tu Liem
City: Hanoi
Country: Vietnam
Website: https://haledco.com/den-led/den-duong-led

Thermally Conductive Plastics Market Growth, Industry Size, Graph, Key Segments, Business Opportunities, Regional Analysis and Forecast to 2027

“Browse 277 market data Tables and 49 Figures spread through 274 Pages and in-depth TOC on “Thermally Conductive Plastics Market””

Thermally Conductive Plastics Market by Type (Polyamide, PBT, Polycarbonate, PPS, PEI, Polysulfones), End-use (Electrical & Electronics, Automotive, Industrial, Aerospace, Healthcare, Telecommunications) and Region – Global Forecast to 2027

The thermally conductive plastics market size is projected to reach USD 298 million by 2027, at a CAGR of 16.2% from USD 121 million in 2021. Asia Pacific was the largest market for thermally conductive plastics in 2021 owing to growth in electrical & electronics, telecommunications, and automotive industries. Miniaturization of electronic components is the major driver for the growth of thermally conductive plastics market. Technological advancement in power electronics and LED lighting technology is expected to increase the demand of thermally conductive plastics for during the forecast period. Rising adoption of electric vehicles and development of advance battery materials is also expected to increase the consumption of thermally conductive plastics during the forecast period. However, geopolitical uncertainties and low thermal conductivity of plastics hinders the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148526587

The major players in the thermally conductive plastics market include Celanese Corporation (US), DSM (The Netherlands), SABIC (Saudi Arabia), BASF (Germany), DuPont (US), LANXESS (Germany), Mitsubishi Engineering-Plastics Corporation (Japan), Ensinger (Germany), TORAY INDUSTRIES, INC.( Japan), and KANEKA CORPORATION (Japan). These players have adopted various growth strategies to expand their presence in the market. New product launches and investment & expansion have been the leading strategies adopted by the major players in the last five years to strengthen their competitiveness and broaden their customer base in the global thermally conductive plastics market.

Celanese Corporation is one of the leading players engaged in manufacturing of high-performance thermally conductive plastics. The company manufactures thermally conductive plastics under the brand CoolPoly. Thermally conductive plastics offered by the company are ideal for housing of LED components, heat sinks, battery cell holders, and others. Celanese Corporation provides thermally conductive plastics based on polymers such as polyamide (PA), polycaprolactam (PA6), and polyphenylene sulfide (PPS) for automotive, electrical & electronics, industrial, telecommunication, and other end-use industries. In 2022, the company has entered into a definitive agreement to acquire DuPont’s mobility & materials business segment which includes specialty materials such as polyamide, polyester, and elastomers.

DSM is a leading player in development of performance materials and provides thermally conductive plastics under the brands Stanyl, Arnite, Xytron, and Akulon. The company offers thermally conductive plastics for electrical & electronics, automotive, industrial equipment, and others. DSM provides polyamide, PET, PBT, and PPS based thermally conductive plastics ideal for gears, lighting modules, thermostat housing, and other applications. The company has a global business presence with manufacturing facilities in North America, Europe, and Asia Pacific. In 2022, the company has established new compounding line in China for Stanyl, Akulon, and Arnite brands to cater electrical & electronics and automotive industries.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=148526587

Another important player in the thermally conductive plastics market is SABIC, a prominent thermally conductive plastics manufacturing company. It offers thermally conductive plastics under the brand KONDUIT in various polymers. SABIC develops thermally conductive plastics for LED heat dissipation applications in the automotive industry. The company has a manufacturing site across North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

Read Our Trending Press Release Below:

Rubber Coated Fabric Manufacturers

Lithium-ion Battery Recycling Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/thermally-conductive-plastics-market-148526587.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Thermally Conductive Plastics Market Growth, Industry Size, Graph, Key Segments, Business Opportunities, Regional Analysis and Forecast to 2027

Tamada Offers Natural Flavours with Zero Preservatives in Premium Organic Red Wines

Tamada, established in 2015, is a family-owned business passionate about bringing the finest organic and preservative-free wines from Georgia to Australia.

Sydney, NSW – February 28, 2024 – Tamada, a distinguished Australian family-owned company, proudly unveils its exclusive collection of premium organic red wine, meticulously curated to cater to wine connoisseurs in search of the purest and healthiest wine alternatives. Rooted in a commitment to authenticity, sustainability, and uncompromising quality, Tamada specialises in importing and distributing preservative-free wines from the historic winemaking region of Georgia.

best-natural-wines

At the heart of Tamada’s organic red wine collection is a dedication to providing a 100% natural and organic experience. Crafted from organically-grown grapes, these wines are a testament to the brand’s pledge to a pure winemaking process, devoid of chemicals, preservatives, added sugar, or sulphites.

Living a healthy lifestyle is at the forefront of Tamada’s philosophy, and their preservative-free wines enable enthusiasts to indulge in the pleasures of wine without compromising on well-being. The brand ensures the best quality by importing organic wines to Australia using refrigerated containers, maintaining premium standards through temperature-controlled storage.

When asked about their preservative free wine, the spokesperson of Tamada replied, “With a focus on quality, authenticity, and sustainability, Tamada, the reputable natural wine shop, has become a trusted name for those seeking premium, natural wine options. Tamada’s organic red wines are more than just a choice; they represent an eco-friendly commitment. By choosing organically-grown wines, consumers actively support a sustainable lifestyle that benefits both personal health and the environment.

Emphasising a commitment to being preservative free wine, Tamada’s organic wines are crafted without harmful additives, providing a guilt-free and conscientious option for wine lovers. The brand’s curated selection showcases premium quality, sustainability, and authenticity.”

Tamada encourages wine enthusiasts to choose their best natural wines for a unique combination of health-conscious choices and delicious flavours. Crafted with a dedication to preserving the true essence of each varietal, Tamada’s organic red wines stand out as a premium and natural choice.

About Tamada:

Tamada is an Australian family-owned company dedicated to importing and distributing authentic, high-quality, preservative-free wines from Georgia, one of the world’s oldest wine-producing regions. With a commitment to quality, authenticity, and sustainability, Tamada offers a curated selection of organic wines for wine enthusiasts seeking the purest and healthiest options.

To learn more, visit https://www.tamada.com.au/.

Media Contact
Company Name: Tamada
Contact Person: Tatiana Zakaidze
Email: Send Email
Phone: (02) 8739 7247
Address:Smithfield
City: Sydney
State: NSW
Country: Australia
Website: http://www.tamada.com.au/

Advanced Endometrial Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Advanced Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ Advanced Endometrial Cancer companies and 25+ pipeline drugs in the Advanced Endometrial Cancer pipeline landscape. It covers the Advanced Endometrial Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Advanced Endometrial Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Advanced Endometrial Cancer Pipeline Report

DelveInsight’s Advanced Endometrial Cancer pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies for Advanced Endometrial Cancer treatment.
The leading companies working in the Advanced Endometrial Cancer market include Incyte Corporation, Byondis B.V., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Ability Pharmaceuticals SL, Zymeworks Inc., AstraZeneca, Eli Lilly and Company, Pfizer, Karyopharm Therapeutics, Genentech, Eli Lilly and Company, Genentech Inc., NETRIS Pharma, Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, Takeda, Mundipharma-EDO GmbH, Zai Lab (Shanghai) Co., Ltd., Haihe Biopharma Co., Ltd., Xencor, Compugen Ltd, Checkpoint Therapeutics Inc., Celon Pharma SA, Dragonfly Therapeutics, and others.
Promising Advanced Endometrial Cancer pipeline therapies in the various stages of development include Envafolimab+Lenvatinib, BKM120, TQB2450 injection, Anlotinib Hydrochloride Capsule, Carboplatin Injection, Pembrolizumab, Lenvatinib, Paclitaxel, Doxorubicin, Arzoxifene Hydrochloride, and others.
On January 2023, 3D Medicines (Sichuan) Co. Ltd announced a study of Phase 2 clinical trials for Envafolimab. This is an open-label, multi-center, multi-corhort Phase II study of Envafolimab alone or with Lenvatinib in patients with advanced endometrial cancer. The primary objective is to evaluate objective response rate of envafolimab alone or with lenvatinib.
On June 2023, Eisai Inc. announced a study of Phase 2 clinical trials for Lenvatinib. To assess the objective response rate (ORR: complete response + partial response [CR+ PR]) of E7080 in subjects with unresectable endometrial cancer and disease progression following platinum-based, first-line chemotherapy.
On July 2023, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. announced a study of Phase 2 clinical trials for TQB2450 injection and Docetaxel injection. This study plans to enroll 69 subjects of endometrial cancer and 5-10 subjects of sarcoma of uterus. The experimental set is divided into lead-in trial and formal trial. The lead-in trial includes 9 subjects to observe the safety of the combination and determine the dosage of anlotinib dihydrochloride capsules before the formal phase.
On August 2023, Tesaro Inc. announced a study of Phase 3 clinical trials for Dostarlimab, Carboplatin, Paclitaxel, and Niraparib. This is a 2 part study. Part 1 is to evaluate the efficacy and safety of dostarlimab plus carboplatin-paclitaxel followed by dostarlimab versus placebo plus carboplatin-paclitaxel followed by placebo; and Part 2 is to evaluate the efficacy and safety of dostarlimab plus carboplatin-paclitaxel followed by dostarlimab plus niraparib versus placebo plus carboplatin-paclitaxel followed by placebo in participants with recurrent or primary advanced (Stage III or IV) endometrial cancer.

Request a sample and discover the recent advances in Advanced Endometrial Cancer Treatment Drugs @ Advanced Endometrial Cancer Infection Pipeline Report

The Advanced Endometrial Cancer pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Advanced Endometrial Cancer drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Advanced Endometrial Cancer clinical trial landscape.

Advanced Endometrial Cancer Overview

Metastatic or advanced uterine (endometrial) cancer is a type of cancer that originated in the lining of the uterus (endometrium) and has spread to distant areas of the body. In general, uterine cancer can metastasize to the rectum or bladder.

Find out more about Advanced Endometrial Cancer Treatment Landscape @ Drugs for Advanced Endometrial Cancer Treatment

Advanced Endometrial Cancer Emerging Drugs Profile

Retifanlimab: Incyte Corporation
Trastuzumab duocarmazine (SYD985): Byondis

Advanced Endometrial Cancer Pipeline Therapeutics Assessment

There are approx. 25+ key companies which are developing the therapies for Advanced Endometrial Cancer. The Advanced Endometrial Cancer companies which have their Advanced Endometrial Cancer drug candidates in the most advanced stage, i.e. phase II include, Incyte Corporation.

Learn more about the emerging Advanced Endometrial Cancer Pipeline Therapies @ Advanced Endometrial Cancer Clinical Trials Assessment

Scope of the Advanced Endometrial Cancer Pipeline Report

Coverage- Global
Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Advanced Endometrial Cancer- Incyte Corporation, Byondis B.V., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Ability Pharmaceuticals SL, Zymeworks Inc., AstraZeneca, Eli Lilly and Company, Pfizer, Karyopharm Therapeutics, Genentech, Eli Lilly and Company, Genentech Inc., NETRIS Pharma, Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, Takeda, Mundipharma-EDO GmbH, Zai Lab (Shanghai) Co., Ltd., Haihe Biopharma Co., Ltd., Xencor, Compugen Ltd, Checkpoint Therapeutics Inc., Celon Pharma SA, Dragonfly Therapeutics, and others.
Advanced Endometrial Cancer pipeline therapies- Envafolimab+Lenvatinib, BKM120, TQB2450 injection, Anlotinib Hydrochloride Capsule, Carboplatin Injection, Pembrolizumab, Lenvatinib, Paclitaxel, Doxorubicin, Arzoxifene Hydrochloride, and others.

Dive deep into rich insights for new drugs for Advanced Endometrial Cancer treatment, Visit @ Advanced Endometrial Cancer Market Drivers and Barriers, and Future Perspective

Table of Content

Introduction
Executive Summary
Advanced Endometrial Cancer: Overview
Pipeline Therapeutics
Therapeutic Assessment
Advanced Endometrial Cancer – DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
Selinexor: Karyopharm Therapeutics
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Retifanlimab: Incyte Corporation
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
Alsevalimab: Five Prime Therapeutics
Drug profiles in the detailed report…..
Inactive Products
Advanced Endometrial Cancer Key Companies
Advanced Endometrial Cancer Key Products
Advanced Endometrial Cancer- Unmet Needs
Advanced Endometrial Cancer- Market Drivers and Barriers
Advanced Endometrial Cancer- Future Perspectives and Conclusion
Advanced Endometrial Cancer Analyst Views
Advanced Endometrial Cancer Key Companies
Appendix

For further information on the Advanced Endometrial Cancer pipeline therapeutics, reach out to Advanced Endometrial Cancer Unmet Needs and Analyst Views

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Advanced Endometrial Cancer Pipeline Outlook Report 2024

Non Muscle Invasive Bladder Cancer Pipeline Outlook Report 2024

DelveInsight’s, “Non-Muscle Invasive Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Non-Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non-Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Muscle Invasive Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Non-Muscle Invasive Bladder Cancer Pipeline Report

DelveInsight’s Non-Muscle Invasive Bladder Cancer pipeline report depicts a robust space with 25+ active players working to develop 30+ pipeline therapies for Non Muscle Invasive Bladder Cancer treatment.
The leading companies working in the Non-Muscle Invasive Bladder Cancer Market include Bristol-Myers Squibb, Pfizer, Asieris Pharmaceuticals, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics, Tollys, and others.
Promising Non-Muscle Invasive Bladder Pipeline Therapies in the various stages of development include CG0070, n-dodecyl-B-D-maltoside, Durvalumab, BCG, cis-UCA solution, and others.
December 2023: Merck Sharp & Dohme LLC announced a study of Phase 3 clinical trials for Pembrolizumab and BCG. This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with BCG, compared to BCG monotherapy, in participants with HR NMIBC that is either persistent or recurrent following adequate BCG induction (Cohort A), or that is naïve to BCG treatment (Cohort B). The primary hypothesis for Cohort A is that the combination of pembrolizumab plus BCG has a superior complete response rate (CRR) as assessed by central pathology review compared to BCG in participants with carcinoma in situ (CIS).
December 2023: Janssen Research & Development LLC announced a study of Phase 2 clinical trials for Erdafitinib. The purpose of this study is to evaluate recurrence-free survival (RFS) in participants treated with erdafitinib vs Investigator’s Choice, for participants with high-risk non-muscle-invasive bladder cancer (NMIBC) who harbor fibroblast growth factor receptor (FGFR) mutations or fusions, and who recurred after bacillus calmette-guerin (BCG) therapy.
September 2023: Protara Therapeutics announced a study of phase 1 & 2 clinical trials for TARA-002. The Phase 1b/2 study (TARA-002-101-Ph1b/2) will be initiated after the RP2D has been established in the Phase 1a dose finding study (TARA-002-101-Ph1a). This Phase 1b/2 (TARA-002-101-Ph1b/2) dose expansion study includes participants with CIS NMIBC (± Ta/T1) with active disease (defined as disease present at last tumor evaluation prior to signing ICF).
September 2023: Pfizer announced a study of phase 3 clinical trials for PF-06801591 and Bacillus Calmette-Guerin. The purpose of this study is to learn about the safety and effects of the study medicine (sasanlimab) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder, has been removed with surgery, and is high risk (Part A) or was previously treated with BCG (Bacillus Calmette Guerin), a standard treatment for bladder cancer (Part B).

Request a sample and discover the recent advances in Non-Muscle Invasive Bladder Cancer Treatment Drugs @ Non-Muscle Invasive Bladder Cancer Pipeline Report

In the Non-Muscle Invasive Bladder Cancer pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Non Muscle Invasive Bladder Cancer collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Non-Muscle Invasive Bladder Cancer Overview

Non muscle-invasive bladder cancer (NMIBC) is a heterogeneous subclassification of urothelial carcinoma with significant variation in individual risk of recurrence and progression to muscle-invasive disease. It is a cancer found in the tissue that lines the inner surface of the bladder. Some people may have symptoms that suggest they have bladder cancer. Others may feel nothing at all. Some symptoms should never be ignored.

Find out more about Non-Muscle Invasive Bladder Cancer Therapeutics Assessment @ Non-Muscle Invasive Bladder Cancer Preclinical and Discovery Stage Products

Non-Muscle Invasive Bladder Cancer Emerging Drugs Profile

APL-1202: Asieris Pharmaceuticals
Pemigatinib: Incyte Corporation
VAX 014: Vaxiion Therapeutics

Non-Muscle Invasive Bladder Cancer Pipeline Therapeutics Assessment

There are approx. 25+ key companies which are developing the Non Muscle Invasive Bladder Cancer therapies. The Non Muscle Invasive Bladder Cancer companies which have their Non Muscle Invasive Bladder Cancer drug candidates in the most advanced stage, i.e. Phase III include, Asieris Pharmaceuticals.

Learn more about the emerging Non-Muscle Invasive Bladder Cancer Pipeline Therapies @ Non-Muscle Invasive Bladder Cancer Clinical Trials Assessment

Scope of the Non-Muscle Invasive Bladder Cancer Pipeline Report

Coverage- Global
Non-Muscle Invasive Bladder Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Non-Muscle Invasive Bladder Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Non-Muscle Invasive Bladder Cancer Companies- Bristol-Myers Squibb, Pfizer, Asieris Pharmaceuticals, Incyte Corporation, Janssen Pharmaceuticals, Theralase Technologies, Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics, Tollys, and others.
Non-Muscle Invasive Bladder Pipeline Therapies- CG0070, n-dodecyl-B-D-maltoside, Durvalumab, BCG, cis-UCA solution, and others.

Dive deep into rich insights for new drugs for Non-Muscle Invasive Bladder Cancer Treatment, Visit @ Non-Muscle Invasive Bladder Cancer Market Drivers and Barriers, and Future Perspective

Table of Content

Introduction
Executive Summary
Non Muscle Invasive Bladder Cancer: Overview
Pipeline Therapeutics
Therapeutic Assessment
Non Muscle Invasive Bladder Cancer– DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
APL-1202: Asieris Pharmaceuticals
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Pemigatinib: Incyte Corporation
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
VAX 014: Vaxiion Therapeutics
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Drug Name: Company Name
Drug profiles in the detailed report…..
Inactive Products
Non Muscle Invasive Bladder Cancer Key Companies
Non Muscle Invasive Bladder Cancer Key Products
Non Muscle Invasive Bladder Cancer- Unmet Needs
Non Muscle Invasive Bladder Cancer- Market Drivers and Barriers
Non Muscle Invasive Bladder Cancer- Future Perspectives and Conclusion
Non Muscle Invasive Bladder Cancer Analyst Views
Non Muscle Invasive Bladder Cancer Key Companies
Appendix

For further information on the Non-Muscle Invasive Bladder Cancer Pipeline therapeutics, reach out to Non-Muscle Invasive Bladder Cancer Unmet Needs and Analyst Views

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non Muscle Invasive Bladder Cancer Pipeline Outlook Report 2024

Chelating Agents Market Insights, Growth, Regional Graph, Opportunities, Share, Global Size, Key Segments and Forecast

“Browse 81 market data tables and 39 figures spread through 136 pages and in-depth TOC on “Chelating Agents Market””

Chelating Agents Market by Type (Non-Biodegradable, Biodegradable), by Application (Pulp & Paper, Cleaning, Water Treatment, Agrochemicals, Personal Care), by Region – Global Forecast to 2025

The global chelating agents market size is expected to grow from USD 6.8 billion in 2020 to USD 8.4 billion by 2025, at a CAGR of 4.2% during the forecast period. The major factor driving the chelating agents market is the increase in demand for potable and treated water and growth in the consumption of cleaning products. Expansions & investments are the key strategy adopted by the key industry players to gain traction in the chelating agents market. This strategy accounted for 43% of all the growth strategies adopted by market players from 2011 to 2015. Companies also adopted the strategy of agreements and partnership to expand their product portfolio. This approach accounted for 38% of all the growth strategies adopted by market players during the above-mentioned period. New product development accounted for 10% of all the growth strategies followed by market players in the chelating agents market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=342

North America and Europe were the most active regions, in terms of strategic initiatives undertaken from 2011 to 2015. Expansion and agreements were the most favored strategy in Europe. Companies such as BASF SE (Germany), Kemira Oyj (U.S.), Cargill Incorporated (U.S.), and Archer Daniels Midland Company (U.S.) made several expansions to serve customers more efficiently and increase their market share.

Major manufacturers, including AkzoNobel N.V. (Netherlands), Dow Chemical Company (U.S.), BASF SE (Germany), Archer Daniel Midland (U.S.), Kemira Oyj (Finland), Cargill Incorporated (U.S.), Lanxess AG (Germany), and Tate & Lyle (UK), have been profiled in this report. These companies have adopted both, organic and inorganic growth strategies such as expansions & investments, agreements & partnerships, acquisitions, and new product launches to strengthen their foothold in the chelating agents market. The players made significant investments in R&D to develop new innovative and eco-friendly products and various application areas. The companies also made their current products available in the emerging markets to develop and capture new market shares. Lanxess (Germany) and BASF SE (Germany) are some of the leading market players adopting this strategy to develop their business. These companies focus on offering advanced chelating agent systems that have relatively high effectiveness in low concentrations and can be used in multiple industries.

Kemira Oyj (Finland) is one of the leading players in the chelating agents market. It accounted for a share of 33.3% of the total development activities, followed by BASF SE (Germany) with 19.0% from 2011 to 2015.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=342

Kemira Oyj (Finland) is the most active player in the chelating agents market. It accounted for the largest share of all the development activities in the chelating agents market. The company follows dynamic growth strategies, focusing on agreements, expansions, acquisitions, and investments to increase its presence in North America, Asia-Pacific, and RoW. The company acquired AkzoNobel’s paper chemical business and came into agreement with Lindstorm Oy (Finland) for its water treatment operations. The company has significantly expanded its chelating agents R&D center and production capacity in Canada and China, respectively. The expansion has strengthened the company’s presence in North America and Asia-Pacific.

BASF SE (Germany) has gained a strong foothold in the chelating agents market. It is focusing on organic growth and has enhanced its product portfolio through various growth strategies such as expansions and new product launches to meet the growing demand from customers. The company recently launched the biodegradable chelating agent, Trilon M, which is a high-performance phosphate alternative for automatic dishwashing detergents, and expanded production facilities for chelating agents at its site in Ludwigshafen, Germany, in order to fulfill the increasing demand in Europe.

Read Our Trending Press Release Below:

Fiber Optics Market

Underwater Concrete Manufacturers

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chelating Agents Market Insights, Growth, Regional Graph, Opportunities, Share, Global Size, Key Segments and Forecast

Cellulosic Fire Protection Intumescent Coatings Market Size, Growth, Graph, Segments, Key Drivers, Opportunities, Top Players and Forecast

“Browse 352 market data Tables and 63 Figures spread through 303 Pages and in-depth TOC on “Cellulosic Fire Protection Intumescent Coatings Market””

Cellulosic Fire Protection Intumescent Coatings Market by Type (Water-borne, Solvent-borne), End-use, Material Type (Acrylic, Epoxy, Alkyd, VAE), Substrate Type (Structural Steel & Cast Iron, Wood), and Region

The global cellulosic fire protection intumescent coatings market size is projected to grow from USD 601 million in 2023 to USD 725 million, at a CAGR of 3.8%. The market for cellulosic fire protection intumescent coatings is poised to experience a significant upswing, largely influenced by a heightened focus on safety measures and an increasing affinity for lightweight construction materials that necessitate enhanced fire protection. This growing awareness of safety standards aligns with stringent regulations and norms that mandate adherence to requisite safety and fire resistance benchmarks, particularly for newly erected structures.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235529408

The symbiotic relationship between urbanization trends and the burgeoning building and construction industry presents a promising avenue for market expansion during the forecast period. As urban landscapes evolve and construction activities escalate, the demand for advanced fire protection solutions gains momentum, thus propelling the growth prospects of cellulosic fire protection intumescent coatings. While the market outlook remains positive, it is essential to acknowledge certain challenges that could influence its trajectory. The utilization of low-cost alternatives, exemplified by cementitious coatings, poses a potential impediment to market advancement. Despite their economic appeal, such alternatives might compromise the comprehensive fire protection capabilities offered by cellulosic fire protection intumescent coatings.

The North American market assumes a prominent and strategic role as a focal point for cellulosic fire protection intumescent coatings, signifying its robust influence in shaping the industry landscape and driving the widespread adoption of these specialized fire safety solutions. Within the dynamic realm of construction and infrastructure, North America’s economic vitality, rigorous safety standards, and evolving urban dynamics position the region as a pivotal hub for the application and integration of cellulosic intumescent coatings.

Across a spectrum of industries and sectors, North America presents a diversified canvas marked by an escalated demand for advanced fire protection protocols. The imperative to safeguard human lives, assets, and vital infrastructure against the threat of fire hazards underscores the compelling necessity for innovative and effective solutions. Cellulosic intumescent coatings, characterized by their capacity to yield a protective char layer that curtails flame propagation and heat transmission, surface as a quintessential cornerstone of holistic fire safety strategies.

The robust construction sector within the region further underscores the salience of cellulosic intumescent coatings. From commercial edifices to industrial installations and residential complexes, these coatings serve as instrumental fortifications, heightening the fire resistance of critical structural elements like steel, cast iron, and concrete. As North America continues its trajectory of urban expansion, marked by high-rise developments and infrastructure projects, cellulosic intumescent coatings’ role in underpinning these structures’ longevity and security assumes heightened significance. The regulatory framework and commitment to safety underscore North America’s distinction as an adopter of cellulosic intumescent coatings. Rigorous codes and standards mandate a premium on fire protection, compelling stakeholders to proactively invest in advanced solutions that seamlessly align with these imperatives. The coatings’ ability to extend evacuation timelines during fire incidents resonates deeply with North America’s unwavering dedication to human safety and prudent risk management.

There are various small, medium, and large players operating in the market. Some of the major market players include Kansai Paints Co. Ltd (Japan), ETEX Group (Belgium), Sika AG (Switzerland), RPM International Inc (US), Jotun (Norway), PPG Industries, Inc (US), The Sherwin-Williams Company (US), and AkzoNobel N.V. (Netherlands). They have adopted various developmental strategies such as investment & expansions, new product launches, mergers & acquisitions, and joint ventures to increase their share in the market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235529408

The Sherwin-Williams Company: The Sherwin-Williams Company is a leading provider of paints, coatings, and related products. With a history dating back to 1866, the company has built a strong reputation for quality and innovation in the industry. Sherwin-Williams offers a wide range of products for both professional and consumer use, including paints, stains, varnishes, and sealants. They also provide expert advice and support to help customers achieve the best results. With a strong focus on sustainability, Sherwin-Williams is committed to developing environmentally friendly solutions. Overall, the company is recognized for its high-quality products and excellent customer service.

PPG Industries, Inc: PPG Industries is a global leader in the production of coatings, paints, and specialty materials. They provide a diverse variety of solutions for sectors like automotive, aerospace, construction, and consumer products. PPG Industries delivers high-quality products that satisfy client demands while decreasing environmental impact, with a strong focus on innovation and sustainability. In order to assure customer satisfaction, they also provide extensive support and services. Overall, PPG sectors, with its vast product range and dedication to quality, is well-positioned to address the unique demands of many sectors.

Read Our Trending Press Release Below:

Isobutyric Acid Manufacturers

Industrial Wastewater Treatment Chemicals Market

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cellulosic-fire-protection-european-building-construction-steelwork-intumescent-coating-market-235529408.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cellulosic Fire Protection Intumescent Coatings Market Size, Growth, Graph, Segments, Key Drivers, Opportunities, Top Players and Forecast

LiFePO4 vs Lead-Acid Batteries Comprehensive Comparison by Redway Power

Redway Power, a pioneering force in battery technology, presents an in-depth exploration into the transformative aspects of LiFePO4 batteries compared to traditional lead-acid counterparts. This comprehensive comparison sheds light on the reasons behind LiFePO4 batteries emerging as a dependable and cost-effective solution for energy storage across various applications.

Redway Power’s analysis affirms that LiFePO4 batteries indeed justify their investment. LiFePO4 batteries surpass lead-acid counterparts with up to four times longer lifespan, making them a durable and cost-effective choice. Ideal for portable electronic devices, LiFePO4 batteries’ lightweight and compact nature enhance versatility and convenience. From safety to environmental friendliness and low maintenance requirements, LiFePO4 batteries offer unmatched benefits across multiple applications.

Redway Power delves into the key reasons behind LiFePO4 batteries revolutionizing energy storage. LiFePO4 batteries ensure superior safety standards, minimizing risks of overheating and explosions, making them ideal for safety-critical applications. With a lifespan of up to ten years or more, LiFePO4 batteries prove to be a durable and cost-effective option for diverse applications. They stand out with faster charging capabilities and maintain optimal performance even in high-temperature environments. Free from toxic heavy metals, LiFePO4 batteries align with environmental sustainability and require minimal maintenance.

Redway Power emphasizes the compelling reasons to invest in LiFePO4 batteries. Outshining other rechargeable options, LiFePO4 batteries offer longevity and cost-effectiveness, making them ideal for electric vehicles and renewable energy storage. Boasting superior energy density, they store more energy in a smaller package, ideal for space-constrained applications. Prioritizing safety, LiFePO4 batteries exhibit high temperature tolerance and lower risks of overheating, crucial for safety-critical applications.

Redway Power highlights the advantages of embracing custom lithium-ion batteries. Custom lithium batteries optimize space, weight, and energy utilization, enhancing performance in applications like electric vehicles. These batteries store more energy in a smaller, lighter package, perfect for portable electronics and wearable devices. With a lifespan exceeding ten years, custom lithium batteries contribute to environmental responsibility by avoiding toxic heavy metals.

In addition, Redway Power underscores the increasing popularity of Lithium Titanate Battery (LTO) by highlighting its significant advantages. LTO batteries stand out with an impressive lifespan of up to 30,000 cycles, ensuring sustained performance for extended periods, a feature particularly prized for longevity-dependent applications. Additionally, their high power capability facilitates efficient delivery of high currents and supports rapid charging and discharging, making them an ideal choice for electric vehicles and high-power devices.

Moreover, LTO batteries demonstrate reliability across a wide temperature range, from -30°C to 55°C, making them suitable for demanding environments subject to temperature fluctuations. Safety is paramount, and LTO batteries offer peace of mind with their excellent safety characteristics, boasting a low risk of thermal runaway or explosion due to their stable chemistry. Redway Power’s emphasis on these advantages underscores the appeal and utility of Lithium Titanate Batteries for diverse energy storage needs.

In conclusion, Redway Power’s comprehensive comparison underscores the superiority of LiFePO4 batteries over lead-acid counterparts. With unmatched longevity, safety features, and environmental sustainability, LiFePO4 batteries emerge as the preferred choice for efficient and reliable energy storage solutions across diverse applications.

For more information, visit Redway Power’s website at https://www.redwaypower.com/lifepo4-vs-lead-acid-batteries/

Media Contact
Company Name: Redway Power, Inc.
Contact Person: Mr. Smith
Email: Send Email
Phone: +86 (755) 28010506
City: Shenzhen
State: Guangdong
Country: China
Website: https://www.redwaypower.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: LiFePO4 vs Lead-Acid Batteries Comprehensive Comparison by Redway Power

New Book “Born to Be All of Me” Hits #1 Best Seller in Family & Personal Growth Category

A groundbreaking new book is already making waves in the spiritual transformation genre; “Born to Be All of Me” hits #1 Best Seller on Amazon. Inspiring up-and-coming author, Amber Susa, takes readers on a profound healing journey from self-abandonment to authentic embodiment. Through the author’s personal experiences and wisdom, readers are guided towards embracing their true selves and fulfilling their soul’s calling.

This transformative book is not just a mere read; it is a roadmap towards discovering one’s divine purpose and living a life of authenticity and fulfillment. With a unique blend of storytelling, practical exercises, and spiritual insights, “Born to Be All of Me” is a must-read for anyone seeking to embark on a journey of self-discovery and empowerment. Grab your copy today and start your own transformational journey towards becoming all of you.

It’s no wonder this book has become a #1 best seller, resonating with countless individuals seeking authenticity and inner transformation.

Author, Amber Susa, is a multifaceted individual who wears many hats in the fields of entrepreneurship, fitness, holistic health, and spiritual wellness. As the founder of Allomi, a sanctuary that prioritizes holistic healing through movement, meditation, and mindfulness, she has created a space for individuals to nurture their physical and mental well-being. With a background in performing arts and a passion for creative expression, Amber’s journey has led her to become a Reiki healer, inspirational speaker, writer, and spiritual mentor.

Her dedication to helping others achieve optimal health and wellness is evident in her one-woman show, “Waking Up to All Of Me,” which explores the integration of the inner child and the empowered woman. Through her performances and teachings, Amber aims to inspire others to live their best lives. Her own transformative healing journey, sparked by low-back pain after becoming a mother, has shaped her mission to encourage personal growth and elevate the collective consciousness by embracing one’s true self. Amber’s commitment to being authentic and embracing all aspects of herself serves as a beacon of empowerment for those around her.

What readers are saying:

5.0 out of 5 stars Pure inspiration & solid gold!

“Amber’s words resonate with me on a deep level! Such beautifully written & eloquent. She shares her toughest times along with her rising up from those ashes, motivating & inspiring anyone to do the same! Love , love, love, this book! A must buy!”

5.0 out of 5 stars Find yourself again

“Amber helps us to realize we never lost ourselves, we were simply buried in conditioning of who we thought we had to be. Born To Be All Of Me is a coming home to self and living a fully expressed life. The author’s vulnerable shares really helped me to better understand my own experiences and break the chains that held me back from being all of myself.”

5.0 out of 5 stars Potent Healing Message! Wish I’d known about it when I was young!

“There’s no other way to say it: This book has the power to change lives! Amber takes us on a potent soul-searching journey of self-examination and self-exploration, as we read along and learn the importance of being our true, authentic selves. This book challenges us to never back down from our dreams or drown out that voice inside that tells us that we don’t have to “fit in” or “stay small” — but we are made for something more!”

Link to purchase “Born To Be All Of Me: Moving Out Of Self-Abandonment Into Authentic Embodiment” on Amazon: http://www.amazon.com/dp/B0CVVLFG97/

Media Contact
Company Name: Amber Susa
Contact Person: Amber Susa
Email: Send Email
Country: United States
Website: www.allomi.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Book \”Born to Be All of Me\” Hits #1 Best Seller in Family & Personal Growth Category